Trial Profile
Efficacy and effects of trimetazidine + enalapril + metoprolol versus enalapril + metoprolol in very elderly hypertensive patients with chronic heart failure New York Heart Association class II with preserved ejection fraction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Sep 2013
Price :
$35
*
At a glance
- Drugs Trimetazidine (Primary) ; Enalapril; Metoprolol
- Indications Chronic heart failure
- Focus Pharmacodynamics; Therapeutic Use
- 30 Sep 2013 New trial record
- 04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.